Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05903092 |
| Title | MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer (MOZART) |
| Acronym | MOZART |
| Recruitment | Suspended |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Hirva Mamdani |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | United States | Details | |
| Karmanos Cancer Center (Wayne State University) | Detroit | Michigan | 48201 | United States | Details | |
| University of Virginia Health System | Charlottesville | Virginia | 22908 | United States | Details |